These effects, along with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the idea of focusing on ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked Problems. At that point, Microsoft https://manleyk257pmf6.blogs100.com/profile